Clinical Trials Browser

Phase 2 × HM781-36B × 30 days × Clear all

NCT03066206 2026-02-20

Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung